Stephen R. Brady, President and CEO at Tempest Therapeutics, Inc. (TPST), bought 35,000 shares at $2.11 ($74K) on 2024-07-03, disclosed to the SEC on 2024-07-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| IMDZ | SELL | 2017-01-06 | $9K | — | Filing → |
| IMDZ | BUY | 2016-07-19 | $10K | — | Filing → |